WHO ICTRP trial
MIrena coil to Reduce Endometrial Neoplastic Abnormalities
ISRCTN31662931 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN31662931 |
|---|---|
| Public title | MIrena coil to Reduce Endometrial Neoplastic Abnormalities |
| Scientific title | Predicting response to progestins for the treatment of endometrial hyperplasia and endometrioid adenocarcinoma of the endometrium |
| Primary sponsor | Central Manchester University Hospitals NHS Trust (CMFT) (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | United Kingdom;England |
| Conditions | Endometrial hyperplasia and endometrioid adenocarcinoma of the endometrium Cancer |
| Interventions | Current intervention as of 11/04/2023: A detailed gynaecological history, including parity, menstrual abnormalities, hormonal and contraceptive use will be taken when recruited. Weight, BMI, age and menopausal status will be assessed. Women… |
| Registration date | Dec 6, 2014 |
| Target size | 150 |
| Secondary IDs | Nil known;Nil known;16746, IRAS 148213 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: